Table 3 Risk factors for visual field defect progression by logistic regression analyses

Age (years)^a

0.98 (0.91–1.06)

0.62

1.06 (0.92–1.29)

0.41

Sex (M/F)

0.91 (0.17–4.88)

0.92

3.02 (0.19–104.7)

0.44

IOP (mmHg)^a

0.56 (0.27–0.85)

0.003*

0.44 (0.11–0.92)

0.02*

LogMAR^a

1.54 (0.001–1829.0)

0.90

192.4 (0.003–3.08 × 10⁸)

0.34

MD (dB)^a

0.92 (0.77–1.07)

0.28

1.01 (0.67–1.45)

0.97

Habitual exercise

0.10 (0.01–0.59)

0.01*

0.04 (0.0003–0.70)

0.02*

Number of anti-glaucoma drugs^a

0.66 (0.33–1.23)

0.20

0.46 (0.07–1.61)

0.23

Escalation of anti-glaucoma therapy

0.53 (0.09–2.83)

0.46

0.58 (0.02–14.36)

0.72